Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies

Management of metastatic genitourinary malignancies has recently been transformed through the use of immune checkpoint inhibitors. The best way to integrate them into local treatment paradigms is still under investigation. To systematically evaluate evidence regarding the use of immunotherapy in the treatment of local disease, in both the perioperative and the metastatic setting. We performed a critical review of PubMed and ClinicalTrials.gov...